Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2022 | Nov. 14, 2022 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2022 | |
Entity File Number | 001-41394 | |
Entity Registrant Name | Prime Number Acquisition I Corp. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 86-2378484 | |
Entity Address, Address Line One | 1129 Northern Blvd., Suite 404 | |
Entity Address, City or Town | Manhasset | |
Entity Address State Or Province | NY | |
Entity Address, Postal Zip Code | 11030 | |
City Area Code | 347 | |
Local Phone Number | 329-1575 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | true | |
Entity Common Stock, Shares Outstanding | 8,461,392 | |
Entity Central Index Key | 0001858180 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false | |
Common Stock | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Common Stock, par value $0.0001 per share | |
Trading Symbol | PNAC | |
Security Exchange Name | NASDAQ | |
Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share | |
Trading Symbol | PNACW | |
Security Exchange Name | NASDAQ | |
Rights, each right exchangeable for one-eighth (1/8) of one share of Class A common stock at the closing of a business combination | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Rights, each right exchangeable for one-eighth (1/8) of one share of Class A common stock at the closing of a business combination | |
Trading Symbol | PNACR | |
Security Exchange Name | NASDAQ | |
Units, each consisting of one share of Common Stock, one-half of one Warrant, and one right | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Common Stock, one-half of one Warrant, and one right | |
Trading Symbol | PNACU | |
Security Exchange Name | NASDAQ |
UNAUDITED CONDENSED BALANCE SHE
UNAUDITED CONDENSED BALANCE SHEETS - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
Current Assets | ||
Cash | $ 540,528 | $ 125,303 |
Prepaid expenses | 172,612 | 0 |
Other receivable | 0 | 700 |
Deferred offering costs | 0 | 247,640 |
Investments held in Trust Account | 66,150,880 | 0 |
Total current assets | 66,864,020 | 373,643 |
Total Assets | 66,864,020 | 373,643 |
Current Liabilities | ||
Accounts payable and accrued expenses | 56,293 | 0 |
Franchise tax payable | 57,523 | 0 |
Income tax payable | 62,839 | 0 |
Promissory note - related party | 0 | 350,000 |
Deferred underwriting fee payable | 2,257,500 | 0 |
Total current liabilities | 2,434,155 | 350,000 |
Total Liabilities | 2,434,155 | 350,000 |
Commitments and Contingencies | ||
Common stock subject to possible redemption, 6,450,000 shares at redemption value of $10.26 per share | 66,150,880 | |
Stockholders' Equity (Deficit) | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding | ||
Additional paid-in capital | 0 | 24,827 |
Accumulated deficit | (1,721,216) | (1,357) |
Total Stockholders' Equity (Deficit) | (1,721,015) | 23,643 |
Total Liabilities, Redeemable Common Stock and Stockholders' Equity (Deficit) | 66,864,020 | 373,643 |
Class A Common Stock Subject to Redemption | ||
Current Liabilities | ||
Common stock subject to possible redemption, 6,450,000 shares at redemption value of $10.26 per share | 66,150,880 | 0 |
Class A Common Stock Not Subject to Redemption | ||
Stockholders' Equity (Deficit) | ||
Common stock value | 201 | 173 |
Class B Common Stock | ||
Stockholders' Equity (Deficit) | ||
Common stock value | $ 0 | $ 0 |
UNAUDITED CONDENSED BALANCE S_2
UNAUDITED CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Class A Common Stock | ||
Common shares, par value, (per share) | $ 0.0001 | |
Common shares, shares authorized | 50,000,000 | |
Common shares, shares issued | 2,011,392 | |
Common shares, shares outstanding | 2,011,392 | |
Class A Common Stock Subject to Redemption | ||
Common stock subject to possible redemption, number of shares | 6,450,000 | 6,450,000 |
Common stock subject to possible redemption, redemption value per share | $ 10.26 | $ 10.26 |
Class A Common Stock Not Subject to Redemption | ||
Common shares, par value, (per share) | $ 0.0001 | $ 0.0001 |
Common shares, shares authorized | 50,000,000 | 50,000,000 |
Common shares, shares issued | 2,011,392 | 1,725,000 |
Common shares, shares outstanding | 2,011,392 | 1,725,000 |
Class B Common Stock | ||
Common shares, par value, (per share) | $ 0.0001 | $ 0.0001 |
Common shares, shares authorized | 2,000,000 | 2,000,000 |
Common shares, shares issued | 0 | 0 |
Common shares, shares outstanding | 0 | 0 |
UNAUDITED CONDENSED STATEMENTS
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 7 Months Ended | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2021 | Sep. 30, 2022 | |
General and administrative expenses | $ 135,145 | $ 225 | $ 756 | $ 245,802 |
Franchise tax expenses | 32,406 | 0 | 0 | 61,650 |
Loss from operations | (167,551) | (225) | (756) | (307,452) |
Interest earned on investment held in Trust Account | 218,589 | 0 | 0 | 234,513 |
Unrealized gain on investments held in Trust Account | 78,720 | 0 | 0 | 126,368 |
Income (loss) before income taxes | 129,757 | (225) | (756) | 53,430 |
Income taxes provision | (62,839) | 0 | 0 | (62,839) |
Net income (loss) | $ 66,918 | $ (225) | $ (756) | $ (9,410) |
Redeemable common stock | ||||
Weighted average shares outstanding, basic | 6,450,000 | 0 | 0 | 3,225,000 |
Weighted average shares outstanding, diluted | 6,450,000 | 3,225,000 | ||
Basic net income (loss) per share | $ 0.41 | $ 0 | $ 0 | $ 1.24 |
Diluted net income (loss) per share | $ 0.41 | $ 1.24 | ||
Non-redeemable common stock | ||||
Weighted average shares outstanding, basic | 2,011,392 | 1,150,000 | 1,000,288 | 1,870,678 |
Weighted average shares outstanding, diluted | 2,011,392 | 1,150,000 | 1,000,288 | 1,870,678 |
Basic net income (loss) per share | $ (1.27) | $ 0 | $ 0 | $ (2.14) |
Diluted net income (loss) per share | $ (1.27) | $ 0 | $ 0 | $ (2.14) |
UNAUDITED CONDENSED STATEMENT_2
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDER'S EQUITY(DEFICIT) - USD ($) | Class A Common Stock Common Stock Initial Public Offering | Class A Common Stock Common Stock Private Placement | Class A Common Stock Common Stock | Class B Common Stock Common Stock | Additional Paid-in Capital Initial Public Offering | Additional Paid-in Capital Private Placement | Additional Paid-in Capital | Accumulated Deficit Initial Public Offering | Accumulated Deficit Private Placement | Accumulated Deficit | Initial Public Offering | Private Placement | Total |
Balance at the beginning at Feb. 24, 2021 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||||||||
Balance at the beginning (in shares) at Feb. 24, 2021 | 0 | 0 | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||||
Net income (loss) | $ 0 | $ 0 | 0 | (444) | (444) | ||||||||
Balance at the end at Mar. 31, 2021 | 0 | 0 | 0 | (444) | (444) | ||||||||
Balance at the beginning at Feb. 24, 2021 | $ 0 | $ 0 | 0 | 0 | 0 | ||||||||
Balance at the beginning (in shares) at Feb. 24, 2021 | 0 | 0 | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||||
Accretion of common stock to redemption value | 0 | ||||||||||||
Net income (loss) | (756) | ||||||||||||
Balance at the end at Sep. 30, 2021 | $ 0 | $ 115 | 24,884 | (756) | 24,244 | ||||||||
Balance at the end (in shares) at Sep. 30, 2021 | 0 | 1,150,000 | |||||||||||
Balance at the beginning at Mar. 31, 2021 | $ 0 | $ 0 | 0 | (444) | (444) | ||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||||
Sale of units | 0 | $ 144 | 24,856 | 0 | 25,000 | ||||||||
Sale of units (in shares) | 1,437,500 | ||||||||||||
Class B common stock issued to initial stockholders | 0 | $ 144 | 24,856 | 0 | 25,000 | ||||||||
Class B common stock issued to initial stockholders (in shares) | 1,437,500 | ||||||||||||
Surrender of Class B common stock | 0 | $ (29) | 29 | 0 | 0 | ||||||||
Surrender of Class B common stock (in shares) | (287,500) | ||||||||||||
Net income (loss) | 0 | $ 0 | 0 | (87) | (87) | ||||||||
Balance at the end at Jun. 30, 2021 | $ 0 | $ 115 | 24,884 | (531) | 24,469 | ||||||||
Balance at the end (in shares) at Jun. 30, 2021 | 0 | 1,150,000 | |||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||||
Net income (loss) | $ 0 | $ 0 | 0 | (225) | (225) | ||||||||
Balance at the end at Sep. 30, 2021 | $ 0 | $ 115 | 24,884 | (756) | 24,244 | ||||||||
Balance at the end (in shares) at Sep. 30, 2021 | 0 | 1,150,000 | |||||||||||
Balance at the beginning at Dec. 31, 2021 | $ 173 | 24,827 | (1,357) | 23,643 | |||||||||
Balance at the beginning (in shares) at Dec. 31, 2021 | 1,725,000 | ||||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||||
Net income (loss) | (9,952) | (9,952) | |||||||||||
Balance at the end at Mar. 31, 2022 | $ 173 | 24,827 | (11,309) | 13,691 | |||||||||
Balance at the end (in shares) at Mar. 31, 2022 | 1,725,000 | ||||||||||||
Balance at the beginning at Dec. 31, 2021 | $ 173 | 24,827 | (1,357) | 23,643 | |||||||||
Balance at the beginning (in shares) at Dec. 31, 2021 | 1,725,000 | ||||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||||
Accretion of common stock to redemption value | (10,540,369) | ||||||||||||
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against accumulated deficit | (360,881) | ||||||||||||
Net income (loss) | (9,410) | ||||||||||||
Balance at the end at Sep. 30, 2022 | $ 201 | 0 | (1,721,216) | (1,721,015) | |||||||||
Balance at the end (in shares) at Sep. 30, 2022 | 2,011,392 | ||||||||||||
Balance at the beginning at Mar. 31, 2022 | $ 173 | 24,827 | (11,309) | 13,691 | |||||||||
Balance at the beginning (in shares) at Mar. 31, 2022 | 1,725,000 | ||||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||||
Sale of units | $ 645 | $ 40 | $ 64,499,355 | $ 3,988,880 | $ 0 | $ 0 | $ 64,500,000 | $ 3,988,920 | |||||
Sale of units (in shares) | 6,450,000 | 398,892 | |||||||||||
Forfeiture of Founder Shares | $ (11) | (11) | 0 | (22) | |||||||||
Forfeiture of Founder Shares (in shares) | (112,500) | ||||||||||||
Underwriter commissions | $ 0 | (3,547,500) | 0 | (3,547,500) | |||||||||
Offering costs | 0 | (571,515) | 0 | (571,515) | |||||||||
Reimbursement of offering expense from underwriter | 0 | 45,750 | 0 | 45,750 | |||||||||
Reclassification of common stock subject to redemption | $ (645) | (59,016,855) | 0 | (59,017,500) | |||||||||
Reclassification of common stock subject to redemption (in shares) | (6,450,000) | ||||||||||||
Allocation of offering costs to common stock subject to redemption | $ 0 | 3,767,869 | 0 | 3,767,869 | |||||||||
Accretion of common stock to redemption value | 0 | (9,190,800) | (1,349,569) | (10,540,369) | |||||||||
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against accumulated deficit | 0 | 0 | (63,572) | (63,572) | |||||||||
Class B common stock issued to initial stockholders | $ 645 | $ 40 | $ 64,499,355 | $ 3,988,880 | $ 0 | $ 0 | $ 64,500,000 | $ 3,988,920 | |||||
Class B common stock issued to initial stockholders (in shares) | 6,450,000 | 398,892 | |||||||||||
Net income (loss) | 0 | 0 | (66,376) | (66,376) | |||||||||
Balance at the end at Jun. 30, 2022 | $ 201 | 0 | (1,490,826) | (1,490,625) | |||||||||
Balance at the end (in shares) at Jun. 30, 2022 | 2,011,392 | ||||||||||||
Increase (Decrease) in Stockholders' Equity | |||||||||||||
Accretion of common stock to redemption value | (10,540,369) | ||||||||||||
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against accumulated deficit | $ 0 | 0 | (297,308) | (297,308) | |||||||||
Net income (loss) | 0 | 0 | 66,918 | 66,918 | |||||||||
Balance at the end at Sep. 30, 2022 | $ 201 | $ 0 | $ (1,721,216) | $ (1,721,015) | |||||||||
Balance at the end (in shares) at Sep. 30, 2022 | 2,011,392 |
UNAUDITED CONDENSED STATEMENT_3
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($) | 7 Months Ended | 9 Months Ended |
Sep. 30, 2021 | Sep. 30, 2022 | |
Cash flows from operating activities: | ||
Net loss | $ (756) | $ (9,410) |
Adjustments to reconcile net cash used in operating activities: | ||
Interest earned on investment held in Trust Account | 0 | (234,513) |
Unrealized gain on investments held in Trust Account | 0 | (126,368) |
Prepaid expenses | 0 | (172,612) |
Accounts payable and accrued expenses | 0 | 56,294 |
Franchise tax payable | 0 | 57,523 |
Income tax payable | 0 | 62,839 |
Net cash used in operating activities | (756) | (366,247) |
Cash Flows from Investing Activities: | ||
Purchase of investment held in Trust Account | 0 | (65,790,000) |
Net cash used in financing activities | 0 | (65,790,000) |
Cash Flows from Financing Activities: | ||
Proceeds from issuance of insider shares to the initial stockholders | 25,000 | 0 |
Proceeds from sale of public units through public offering | 0 | 64,500,000 |
Proceeds from sale of private placement units | 0 | 3,988,920 |
Proceeds from promissory note- related party | 200,000 | 0 |
Reimbursement of expenses from underwriter | 0 | 45,750 |
Repayment of promissory note to related party | 0 | (350,000) |
Payment of underwriters' commissions | 0 | (1,290,000) |
Payment of deferred offering costs | (174,640) | (323,198) |
Net cash provided by financing activities | 50,360 | 66,571,472 |
Net change in cash | 49,604 | 415,225 |
Cash, beginning of the period | 0 | 125,303 |
Cash, end of the period | 49,604 | 540,528 |
Supplemental Disclosure of Non-cash Financing Activities | ||
Initial classification of common stock subject to redemption | 0 | 59,017,500 |
Allocation of offering costs to common stock subject to redemption | 0 | 3,767,869 |
Accretion of common stock to redemption value | 0 | 10,540,369 |
Subsequent measurement of common stock to redemption value | $ 0 | $ 360,881 |
Description of Organization and
Description of Organization and Business Operations | 9 Months Ended |
Sep. 30, 2022 | |
Description of Organization and Business Operations | |
Description of Organization and Business Operations | Note 1 — Description of Organization and Business Operations Prime Number Acquisition I Corp. (the “Company”) is a newly organized blank check company incorporated as a Delaware corporation on February 25, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is actively searching and identifying suitable Business Combination target. The Company is an early stage and emerging growth company and, as such, it is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2022, the Company had not commenced any operations. Activities before May 17, 2022 are related with the formation and IPO, while the activities after May 17, 2022 are mainly focused on searching and identifying the Business Combination target. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The Company’s sponsors are Prime Number Acquisition LLC (“Sponsor A”) and Glorious Capital LLC (“Sponsor B”) (collectively the “Sponsors”), both are Delaware limited liability companies. The registration statement for the Company’s IPO became effective on May 12, 2022. On May 17, 2022, the Company consummated the initial public offering (the “IPO”) of 6,450,000 units (the “Public Units”) which included 450,000 units issued upon the partial exercise of the underwriters’ over-allotment option. The Public Units were sold at an offering price of $10.00 per unit, with each Public Unit consists of one share (the “Public Shares”) of the Company’s Class A common stock (the “Class A common stock”), one half Upon the closing of the IPO and the private placement on May 17, 2022, the proceeds of $65,790,000 (or $10.20 per Public Unit) in the aggregate from the IPO and the private placement were placed in a trust account (the “Trust Account” as defined in Note 5) with Wilmington Trust, N.A. acting as trustee and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), and that invest only in direct U.S. government treasury obligations. These funds will not be released until the earlier of the completion of the initial Business Combination or the liquidation due to the Company’s failure to complete a Business Combination within the applicable period of time. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s holders of its outstanding Public Shares (the “Public Stockholders”). In addition, interest income earned on the funds in the Trust Account may be released to the Company to pay its income or other tax obligations. With these exceptions, expenses incurred by the Company may be paid prior to a Business Combination only from the net proceeds of the IPO and private placement not held in the Trust Account. Pursuant to Nasdaq listing rules, the Company’s initial Business Combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust Account (excluding any deferred underwriting discounts and commissions and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial Business Combination, although the Company may structure a Business Combination with one or more target businesses whose fair market value significantly exceeds 80% of the Trust Account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.20 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsors and any of the Company’s officers or directors that may hold Founder Shares (as defined in Note 5) (the “Initial Stockholders”) have agreed (a) to vote their Founder Shares, the Private Shares, and any Public Shares purchased during or after the IPO in favor of approving a Business Combination and (b) not to convert any shares (including the Insider Shares) in connection with a stockholder vote to approve, or sell the shares to the Company in any tender offer in connection with, a proposed Business Combination. The Company’s Initial Stockholders have agreed (A) to vote their Founder Shares, Private Shares and any Public Shares they own in favor of any proposed Business Combination, (B) not to propose, or vote in favor of, prior to and unrelated to an initial Business Combination, an amendment to the Company’s certificate of incorporation that would affect the substance or timing of the Company’s redemption obligation to redeem all public shares if the Company cannot complete an initial Business Combination within the Combination Period (as defined below), unless the Company provides Public Stockholders an opportunity to redeem their public shares in conjunction with any such amendment, (C) not to redeem any shares, including Founder Shares, Private Shares and any Public Shares they own into the right to receive cash from the Trust Account in connection with a stockholder vote to approve the Company’s proposed initial Business Combination or sell any shares to the Company in any tender offer in connection with its proposed initial Business Combination, and (D) that the Founder Shares and Private Shares shall not participate in any liquidating distribution upon winding up if a Business Combination is not consummated. If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold the IPO. The Initial Stockholders and underwriters have agreed (a) to waive their redemption rights with respect to the Insider Shares, Private Shares, and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose, or vote in favor of, an amendment to the Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until May 17, 2023 (or November 17, 2023 if the Company extends the period of time to consummate a Business Combination) to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable, and less interest to pay dissolution expenses) divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Initial Stockholders have agreed to waive their liquidation rights with respect to the Founder Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The Underwriters (as defined in Note 5) have agreed to waive their rights to their Deferred Underwriting Commissions (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.20. In order to protect the amounts held in the Trust Account, the Sponsors have agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.20 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under our indemnity of the Underwriters of this IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsors will not be responsible to the extent of any liability for such third party claims. Going Concern As of September 30, 2022, the Company had cash of $540,528 and a working capital of $536,485 (excluding investments held in trust account and deferred underwriting fee payable). The Company’s liquidity needs up to the closing of the IPO on May 17, 2022 had been satisfied through proceeds from notes payable and advances from related party and from the issuance of common stock. The Company has 12 months from the closing of the IPO to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company with working capital. The Company’s management plans to continue its efforts to complete a Business Combination within the Combination Period after the closing of the IPO. If the estimated costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to its Business Combination. Moreover, the Company may need to obtain additional financing either to complete its Business Combination or because it becomes obligated to redeem a significant number of public shares upon consummation of its Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, the Company would only complete such financing simultaneously with the completion of our Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements — Going Concern,” management has determined that mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance of the financial statements. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s future financial position, results of its operations and/or search for a target company, there has not been a significant impact as of the date of these financial statements. The financial statements do not include any adjustments that might result from the future outcome of this uncertainty. Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. |
Significant Accounting Policies
Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2022 | |
Significant Accounting Policies | |
Significant Accounting Policies | Note 2 — Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates In preparing these financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $540,528 and $125,303 in cash as of September 30, 2022 and December 31, 2021 and none in cash equivalents for both periods. Deferred Offering Costs The Company complies with the requirements of Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (the “ASC”) Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Deferred offering costs were $4,117,889 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the IPO and charged to stockholders’ equity upon the completion of the IPO. Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 -270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods under ASC 740-270-30-5. The Company’s effective tax rate was 42.87% and 0.00% for the three months ended September 30 30, 2022 and 2021, respectively, and 118.14% and 0.00% for the nine months ended September 30, 2022 and for the period from February 25, 2021 (inception) through September 30, 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ended September 30, 2022 and 2021, for the nine months ended September 30, 2022 and for the period from February 25, 2021 (inception) through September 30, 2021, due to the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture by the Initial Stockholders. Weighted average shares were reduced for the effect of an aggregate of 225,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised in full by the Underwriters. At September 30, 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. As a result of the underwriters’ partial exercise of their over-allotment option on May 17, 2022, 112,500 insider shares were forfeited on May 23, 2022. On June 3, 2022, the Sponsors executed cancellation notices to the transfer agent to forfeit the remaining 112,500 shares for no consideration. The net income (loss) per share presented in the unaudited condensed statement of operations is based on the following: For the three For the nine months months ended ended September 30, September 30, 2022 2022 Net income (loss) $ 66,918 $ (9,410) Accretion of common stock to redemption value (10,540,369) (10,540,369) Subsequent measurement of common stock subject to redemption value (297,308) (360,881) Net loss including accretion of common stock to redemption value $ (10,770,759) $ (10,910,660) Three months ended September 30, 2022 Non- Redeemable redeemable shares shares Basic and diluted net income/(loss) per share: Numerators: Allocation of net loss including accretion of common stock $ (8,210,398) $ (2,560,361) Accretion of common stock to redemption value 10,540,369 — Subsequent measurement of common stock subject to redemption value 297,308 — Allocation of net income (loss) $ 2,627,279 $ (2,560,361) Denominators: Weighted-average shares outstanding 6,450,000 2,011,392 Basic and diluted net income/(loss) per share $ 0.41 $ (1.27) Nine months ended September 30, 2022 Non- Redeemable redeemable shares shares Basic and diluted net income/(loss) per share: Numerators: Allocation of net loss including accretion of common stock $ (6,905,241) $ (4,005,420) Accretion of common stock to redemption value 10,540,369 — Subsequent measurement of common stock subject to redemption value 360,881 — Allocation of net income (loss) $ 3,996,009 $ (4,005,420) Denominators: Weighted-average shares outstanding 3,225,000 1,870,678 Basic and diluted net income/(loss) per share $ 1.24 $ (2.14) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 825, “Financial Instruments,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company determined that upon further review of the warrant agreement, the Public Warrants issued pursuant to the warrant agreement qualify for equity accounting treatment. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of shares of redeemable common stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. Recent Accounting Pronouncements In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 for the Company and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statement. |
Initial Public Offering
Initial Public Offering | 9 Months Ended |
Sep. 30, 2022 | |
Initial Public Offering. | |
Initial Public Offering | Note 3 — Initial Public Offering Pursuant to the IPO on May 17, 2022, the Company sold 6,450,000 Public Units which included 450,000 units issued upon the partial exercise of the underwriters’ over-allotment option. Each Public Unit consists of one share of Class A common stock, $0.0001 par value per share, one-half one-eighth one-eighth All of the 6,450,000 Public Shares sold as part of the Public Units in the IPO contain a redemption feature which allows for the redemption of such Public Shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. The Company’s redeemable Class A common stock is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e. a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). As of September 30, 2022, the shares of Class A common stock reflected on the balance sheet are reconciled in the following table. As of September 30, 2022 Gross proceeds $ 64,500,000 Less: Proceeds allocated to Public Warrants (322,500) Proceeds allocated to Public Rights (5,160,000) Offering costs of Public Shares (3,767,868) Plus: Accretion of carrying value to redemption value 10,901,248 Common stock subject to possible redemption $ 66,150,880 |
Private Placement
Private Placement | 9 Months Ended |
Sep. 30, 2022 | |
Private Placement. | |
Private Placement | Note 4 — Private Placement Simultaneously with the closing of the IPO, the Company sold an aggregate of 398,892 Private Shares, including 349,032 shares to Sponsor A and 49,860 shares to Sponsor B, at a purchase price of $10.00 per Private Share, generating gross proceeds of $3,988,920 (including $3,490,320 from Sponsor A and $498,600 from Sponsor B). The net proceeds from the Private Shares were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Shares will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Share will expire worthless. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2022 | |
Related Party Transactions | |
Related Party Transactions | Note 5 — Related Party Transactions Promissory Note - Related Party On March 19, 2021, Sponsor A agreed to loan the Company up to an aggregate amount of $400,000 to be used, in part, for transaction costs incurred in connection with IPO (the “Promissory Note”). The Promissory Note is unsecured, interest-free and due at the earlier of August 31, 2022 or closing of the IPO. The Company repaid the $350,000 outstanding balance upon the closing of the IPO on May 17, 2022. Related Party Loans In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Initial Stockholders or their affiliates may, but are not obligated to, loan us funds as may be required. If the Company completes an initial Business Combination, it would repay such loaned amounts (the “Working Capital Loans”). In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the U.S. based Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Certain amount of such loans may be convertible into working capital shares at $10.00 per share at the option of the lender. The working capital shares would be identical to the shares sold in the private placement. As of September 30, 2022, the Company had no borrowings under the Working Capital Loans. Founder Shares On April 7, 2021, Sponsor A and Sponsor B acquired 1,357,000 shares and 80,500 shares of Class B common stock, respectively. On May 28, 2021, Sponsor A and Sponsor B surrendered 271,400 and 16,100 shares of Class B common stock, respectively, without consideration. On December 22, 2021, the Company effected a 1.5 for 1 stock split of Class B common stock resulting the Sponsors holding 1,725,000 shares of Class B common stock. On December 28, 2021, the Sponsors converted their shares of Class B common stock into 1,725,000 shares of Class A common stock on a one-for-one The Initial Stockholders have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of their Founder Shares until, with respect to 50% of the Founder Shares, the earlier of six months after the consummation of a Business Combination and the date on which the closing price of the Class A common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing after a Business Combination and, with respect to the remaining 50% of the insider shares, until the six months after the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Administrative Services Agreement The Company has agreed, commencing on the effective date of the prospectus, to pay Sponsor A up to $10,000 per month for office space, administrative and shared personnel support services. However, pursuant to the terms of such agreement, the Company may delay payment of such monthly fee upon a determination by the audit committee that there are insufficient funds held outside the trust to pay actual or anticipated expenses in connection with the initial Business Combination. Any such unpaid amount will accrue without interest and be due and payable no later than the date of the consummation of the initial Business Combination. This arrangement will terminate upon the earlier of (a) completion of a Business Combination or (b) twelve months after the completion of the IPO. For the three months and nine months ended September 30, 2022, the Company incurred $36,129 and $46,129, respectively, in fees for these services, of which $46,129 and none were included in accrued expenses in the accompanying condensed unaudited balance sheets September 30, 2022 and December 31, 2021, respectively. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2022 | |
Commitments and Contingencies | |
Commitments and Contingencies | Note 6 — Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Shares and working capital shares issuable upon conversion of working capital loans, if any, will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of this offering, requiring us to register such securities for resale. The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company has granted Prime Number Capital, LLC and WestPark Capital, Inc. (collectively referred to as the “Underwriters”), a 45-day option from the date of the prospectus to purchase up to 900,000 Public Units (one share of Class A common stock, one The Underwriters were paid a cash underwriting discount of 2.0% of the gross proceeds of the IPO, or $1,290,000. In addition, the underwriters will be entitled to a deferred fee of 3.5% of the gross proceeds of the IPO, or $2,257,500 (the “Deferred Underwriting Commissions”), which will be paid upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement. |
Stockholders' Equity
Stockholders' Equity | 9 Months Ended |
Sep. 30, 2022 | |
Stockholders' Equity | |
Stockholders' Equity | Note 7 — Stockholders’ Equity Preferred Stock -- outstanding Class A Common Stock outstanding Class B Common Stock -- outstanding Rights — one-eighth If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Rights will not receive any of such funds with respect to their Rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Rights, and the Rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the Rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the Rights. Accordingly, Accordingly, the Rights may expire worthless. Warrants — In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to our founders or their affiliates, without taking into account any founder shares held by founders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination (net of redemption), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Price”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Price, and the $16.50 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price. The Company may redeem the outstanding Public Warrants at any time while the Warrants are exercisable: ● in whole and not in part; ● at a price of $0.01 per Warrant; ● upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the 30 - day redemption period; ● if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 - trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the to the warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Except as described above, no warrants will be exercisable and the Company will not be obligated to issue common stock unless at the time a holder seeks to exercise such warrant, a prospectus relating to the Class A common stock issuable upon exercise of the warrants is current and the common stock have been registered or qualified or deemed to be exempt under the securities laws of the state of residence of the holder of the warrants. Under the terms of the warrant agreement, the Company has agreed to use its best efforts to meet these conditions and to maintain a current prospectus relating to the common stock issuable upon exercise of the warrants until the expiration of the warrants. However, the Company cannot assure that it will be able to do so and, if the Company does not maintain a current prospectus relating to the common stock issuable upon exercise of the warrants, holders will be unable to exercise their warrants and the Company will not be required to settle any such warrant exercise. If the prospectus relating to the Class A common stock issuable upon the exercise of the warrants is not current or if the common stock is not qualified or exempt from qualification in the jurisdictions in which the holders of the warrants reside, the Company will not be required to net cash settle or cash settle the warrant exercise, the warrants may have no value, the market for the warrants may be limited and the warrants may expire worthless. |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Measurements | |
Fair Value Measurements | Note 8 — Fair Value Measurements The fair value of the Company’s consolidated financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on the assessment of the assumptions that market participants would use in pricing the asset or liability. As of September 30, 2022, assets held in the Trust Account were entirely comprised of marketable securities. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. Significant Significant Quoted Prices Other Other in Active Observable Unobservable Markets Inputs Inputs September 30, 2022 (Level 1) (Level 2) (Level 3) Assets Marketable Securities in the Trust Account 66,150,880 66,150,880 — — |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2022 | |
Subsequent Events | |
Subsequent Events | Note 9 — Subsequent Events In accordance with ASC 855, “Subsequent Events,” the Company evaluated subsequent events and transactions that occurred after the balance sheet date up to November 14, 2022 the date that the financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Significant Accounting Policies | |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates In preparing these financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $540,528 and $125,303 in cash as of September 30, 2022 and December 31, 2021 and none in cash equivalents for both periods. |
Deferred Offering Costs | Deferred Offering Costs The Company complies with the requirements of Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (the “ASC”) Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Deferred offering costs were $4,117,889 consisting principally of underwriting, legal, accounting and other expenses that are directly related to the IPO and charged to stockholders’ equity upon the completion of the IPO. |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 -270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in interim periods under ASC 740-270-30-5. The Company’s effective tax rate was 42.87% and 0.00% for the three months ended September 30 30, 2022 and 2021, respectively, and 118.14% and 0.00% for the nine months ended September 30, 2022 and for the period from February 25, 2021 (inception) through September 30, 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ended September 30, 2022 and 2021, for the nine months ended September 30, 2022 and for the period from February 25, 2021 (inception) through September 30, 2021, due to the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company may be subject to potential examination by federal and state taxing authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. |
Net Loss Per Share | Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture by the Initial Stockholders. Weighted average shares were reduced for the effect of an aggregate of 225,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised in full by the Underwriters. At September 30, 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. As a result of the underwriters’ partial exercise of their over-allotment option on May 17, 2022, 112,500 insider shares were forfeited on May 23, 2022. On June 3, 2022, the Sponsors executed cancellation notices to the transfer agent to forfeit the remaining 112,500 shares for no consideration. The net income (loss) per share presented in the unaudited condensed statement of operations is based on the following: For the three For the nine months months ended ended September 30, September 30, 2022 2022 Net income (loss) $ 66,918 $ (9,410) Accretion of common stock to redemption value (10,540,369) (10,540,369) Subsequent measurement of common stock subject to redemption value (297,308) (360,881) Net loss including accretion of common stock to redemption value $ (10,770,759) $ (10,910,660) Three months ended September 30, 2022 Non- Redeemable redeemable shares shares Basic and diluted net income/(loss) per share: Numerators: Allocation of net loss including accretion of common stock $ (8,210,398) $ (2,560,361) Accretion of common stock to redemption value 10,540,369 — Subsequent measurement of common stock subject to redemption value 297,308 — Allocation of net income (loss) $ 2,627,279 $ (2,560,361) Denominators: Weighted-average shares outstanding 6,450,000 2,011,392 Basic and diluted net income/(loss) per share $ 0.41 $ (1.27) Nine months ended September 30, 2022 Non- Redeemable redeemable shares shares Basic and diluted net income/(loss) per share: Numerators: Allocation of net loss including accretion of common stock $ (6,905,241) $ (4,005,420) Accretion of common stock to redemption value 10,540,369 — Subsequent measurement of common stock subject to redemption value 360,881 — Allocation of net income (loss) $ 3,996,009 $ (4,005,420) Denominators: Weighted-average shares outstanding 3,225,000 1,870,678 Basic and diluted net income/(loss) per share $ 1.24 $ (2.14) |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 825, “Financial Instruments,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. |
Warrants | Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company determined that upon further review of the warrant agreement, the Public Warrants issued pursuant to the warrant agreement qualify for equity accounting treatment. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. |
Common Stock Subject to Possible Redemption | Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of shares of redeemable common stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 for the Company and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statement. |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Significant Accounting Policies | |
Summary of net income (loss) per share | For the three For the nine months months ended ended September 30, September 30, 2022 2022 Net income (loss) $ 66,918 $ (9,410) Accretion of common stock to redemption value (10,540,369) (10,540,369) Subsequent measurement of common stock subject to redemption value (297,308) (360,881) Net loss including accretion of common stock to redemption value $ (10,770,759) $ (10,910,660) Three months ended September 30, 2022 Non- Redeemable redeemable shares shares Basic and diluted net income/(loss) per share: Numerators: Allocation of net loss including accretion of common stock $ (8,210,398) $ (2,560,361) Accretion of common stock to redemption value 10,540,369 — Subsequent measurement of common stock subject to redemption value 297,308 — Allocation of net income (loss) $ 2,627,279 $ (2,560,361) Denominators: Weighted-average shares outstanding 6,450,000 2,011,392 Basic and diluted net income/(loss) per share $ 0.41 $ (1.27) Nine months ended September 30, 2022 Non- Redeemable redeemable shares shares Basic and diluted net income/(loss) per share: Numerators: Allocation of net loss including accretion of common stock $ (6,905,241) $ (4,005,420) Accretion of common stock to redemption value 10,540,369 — Subsequent measurement of common stock subject to redemption value 360,881 — Allocation of net income (loss) $ 3,996,009 $ (4,005,420) Denominators: Weighted-average shares outstanding 3,225,000 1,870,678 Basic and diluted net income/(loss) per share $ 1.24 $ (2.14) |
Initial Public Offering (Tables
Initial Public Offering (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Initial Public Offering. | |
Summary of reconciliation of shares of Class A common stock | As of September 30, 2022 Gross proceeds $ 64,500,000 Less: Proceeds allocated to Public Warrants (322,500) Proceeds allocated to Public Rights (5,160,000) Offering costs of Public Shares (3,767,868) Plus: Accretion of carrying value to redemption value 10,901,248 Common stock subject to possible redemption $ 66,150,880 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Measurements | |
Summary of assets that are measured at fair value on a recurring basis | Significant Significant Quoted Prices Other Other in Active Observable Unobservable Markets Inputs Inputs September 30, 2022 (Level 1) (Level 2) (Level 3) Assets Marketable Securities in the Trust Account 66,150,880 66,150,880 — — |
Description of Organization a_2
Description of Organization and Business Operations (Details) | 7 Months Ended | 9 Months Ended | ||
May 17, 2022 USD ($) $ / shares shares | Sep. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) item | Dec. 31, 2021 USD ($) | |
Subsidiary, Sale of Stock [Line Items] | ||||
Condition for future business combination number of businesses minimum | item | 1 | |||
Gross proceeds from issuance initial public offering | $ | $ 0 | $ 64,500,000 | ||
Sale of stock, price per share | $ / shares | $ 10.20 | |||
Condition for future business combination use of proceeds percentage | 80 | |||
Condition for future business combination threshold percentage ownership | 50 | |||
Redemption limit percentage without prior consent | 15 | |||
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent) | 100% | |||
Cash | $ | 540,528 | $ 125,303 | ||
Working capital of deficit | $ | $ 536,485 | |||
Public unit | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Sale of stock, price per share | $ / shares | $ 10.20 | |||
Initial Public Offering | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of units sold | 6,450,000 | |||
Purchase price, per unit | $ / shares | $ 10 | |||
Gross proceeds from issuance initial public offering | $ | $ 64,500,000 | |||
Proceeds from sale of stock | $ | $ 65,790,000 | |||
Initial Public Offering | Public unit | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Sale of stock, price per share | $ / shares | $ 10.20 | |||
Initial Public Offering | Class A Common Stock | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of shares in a unit | 1 | |||
Initial Public Offering | Warrants | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of warrants or rights in the unit | 0.5 | |||
Initial Public Offering | Rights | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of warrants or rights in the unit | 1 | |||
Initial Public Offering | Rights | Class A Common Stock | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of warrants or rights in the unit | 0.125 | |||
Private Placement | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of units sold | 398,892 | |||
Purchase price, per unit | $ / shares | $ 10 | |||
Gross proceeds from issuance initial public offering | $ | $ 3,988,920 | |||
Over-allotment option | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of units sold | 450,000 | |||
Over-allotment option | Class A Common Stock | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of shares in a unit | 1 | |||
Over-allotment option | Warrants | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of warrants or rights in the unit | 0.5 | |||
Over-allotment option | Rights | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of warrants or rights in the unit | 1 | |||
Sponsor A | Private Placement | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of units sold | 349,032 | |||
Gross proceeds from issuance initial public offering | $ | $ 3,490,320 | |||
Sponsor B | Private Placement | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of units sold | 49,860 | |||
Gross proceeds from issuance initial public offering | $ | $ 498,600 |
Significant Accounting Polici_4
Significant Accounting Policies (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 7 Months Ended | 9 Months Ended | |||||
Feb. 28, 2021 | Mar. 31, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2021 | Sep. 30, 2021 | Sep. 30, 2022 | Jun. 03, 2022 | May 17, 2022 | Dec. 31, 2021 | |
Securities Financing Transaction [Line Items] | ||||||||||
Cash | $ 540,528 | $ 540,528 | $ 125,303 | |||||||
Cash equivalents | 0 | 0 | $ 0 | |||||||
Deferred offering costs | $ 4,117,889 | $ 4,117,889 | ||||||||
Effective tax rate | 42.87% | 0% | 0% | 118.14% | ||||||
Statutory tax rate | 21% | 21% | 21% | 21% | 21% | 21% | ||||
Unrecognized tax benefits | $ 0 | $ 0 | ||||||||
Unrecognized tax benefits accrued for interest and penalties | $ 0 | $ 0 | ||||||||
Sponsor | ||||||||||
Securities Financing Transaction [Line Items] | ||||||||||
Maximum shares subject to forfeiture | 112,500 | |||||||||
Over-allotment option | ||||||||||
Securities Financing Transaction [Line Items] | ||||||||||
Shares subject to forfeiture | 225,000 | 225,000 | 112,500 |
Significant Accounting Polici_5
Significant Accounting Policies - Net income (loss) per share (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 7 Months Ended | 9 Months Ended | |||||
Sep. 30, 2022 | Mar. 31, 2021 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2021 | Jun. 30, 2021 | Sep. 30, 2021 | Sep. 30, 2022 | |
Net income (loss) | $ (444) | $ 66,918 | $ (66,376) | $ (9,952) | $ (225) | $ (87) | $ (756) | $ (9,410) | |
Accretion of common stock to redemption value | $ (10,901,248) | (10,540,369) | (10,540,369) | 0 | (10,540,369) | ||||
Subsequent measurement of common stock subject to redemption value | (297,308) | (63,572) | (360,881) | ||||||
Net loss including accretion of common stock to redemption value | (10,770,759) | (10,910,660) | |||||||
Numerators: | |||||||||
Allocation of net loss including accretion of common stock | (10,770,759) | (10,910,660) | |||||||
Accretion of common stock to redemption value | $ 10,901,248 | 10,540,369 | 10,540,369 | $ 0 | 10,540,369 | ||||
Subsequent measurement of common stock subject to redemption value | (297,308) | $ (63,572) | (360,881) | ||||||
Redeemable common stock | |||||||||
Accretion of common stock to redemption value | 10,540,369 | (10,540,369) | |||||||
Subsequent measurement of common stock subject to redemption value | 297,308 | 360,881 | |||||||
Net loss including accretion of common stock to redemption value | (8,210,398) | (6,905,241) | |||||||
Numerators: | |||||||||
Allocation of net loss including accretion of common stock | (8,210,398) | (6,905,241) | |||||||
Accretion of common stock to redemption value | (10,540,369) | 10,540,369 | |||||||
Subsequent measurement of common stock subject to redemption value | 297,308 | 360,881 | |||||||
Allocation of net income (loss) | $ 2,627,279 | $ 3,996,009 | |||||||
Denominators: | |||||||||
Weighted average shares outstanding, basic | 6,450,000 | 0 | 0 | 3,225,000 | |||||
Weighted average shares outstanding, diluted | 6,450,000 | 3,225,000 | |||||||
Basic net income/(loss) per share | $ 0.41 | $ 0 | $ 0 | $ 1.24 | |||||
Diluted net income/(loss) per share | $ 0.41 | $ 1.24 | |||||||
Non-redeemable common stock | |||||||||
Net loss including accretion of common stock to redemption value | $ (2,560,361) | $ (4,005,420) | |||||||
Numerators: | |||||||||
Allocation of net loss including accretion of common stock | (2,560,361) | (4,005,420) | |||||||
Allocation of net income (loss) | $ (2,560,361) | $ (4,005,420) | |||||||
Denominators: | |||||||||
Weighted average shares outstanding, basic | 2,011,392 | 1,150,000 | 1,000,288 | 1,870,678 | |||||
Weighted average shares outstanding, diluted | 2,011,392 | 1,150,000 | 1,000,288 | 1,870,678 | |||||
Basic net income/(loss) per share | $ (1.27) | $ 0 | $ 0 | $ (2.14) | |||||
Diluted net income/(loss) per share | $ (1.27) | $ 0 | $ 0 | $ (2.14) |
Initial Public Offering (Detail
Initial Public Offering (Details) - $ / shares | 9 Months Ended | |
May 17, 2022 | Sep. 30, 2022 | |
Subsidiary, Sale of Stock [Line Items] | ||
Number of shares issuable per warrant or right | 1 | |
Exercise price of warrants | $ 11.50 | |
Minimum threshold written notice period for redemption of public warrants | 30 days | |
Class A Common Stock | ||
Subsidiary, Sale of Stock [Line Items] | ||
Common shares, par value, (per share) | $ 0.0001 | |
Number of shares issuable per warrant or right | 0.125 | |
Initial Public Offering | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of units sold | 6,450,000 | |
Initial Public Offering | Class A Common Stock | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of shares in a unit | 1 | |
Common shares, par value, (per share) | $ 0.0001 | |
Initial Public Offering | Warrants | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of warrants or rights in the unit | 0.5 | |
Minimum threshold written notice period for redemption of public warrants | 30 days | |
Warrants exercisable term from the closing of the initial public offering | 12 months | |
Warrants expiration term | 5 years | 5 years |
Initial Public Offering | Warrants | Class A Common Stock | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of shares issuable per warrant or right | 1 | |
Exercise price of warrants | $ 11.50 | |
Initial Public Offering | Rights | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of warrants or rights in the unit | 1 | |
Initial Public Offering | Rights | Class A Common Stock | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of warrants or rights in the unit | 0.125 | |
Over-allotment option | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of units sold | 450,000 | |
Over-allotment option | Class A Common Stock | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of shares in a unit | 1 | |
Over-allotment option | Warrants | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of warrants or rights in the unit | 0.5 | |
Over-allotment option | Rights | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of warrants or rights in the unit | 1 |
Initial Public Offering - Class
Initial Public Offering - Class A common stock reflected on the balance sheet (Details) - USD ($) | 3 Months Ended | 7 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | |
Class of Warrant or Right [Line Items] | |||||
Gross proceeds | $ 64,500,000 | ||||
Offering costs of Public Shares | (3,767,868) | ||||
Accretion of common stock to redemption value | 10,901,248 | $ 10,540,369 | $ 10,540,369 | $ 0 | $ 10,540,369 |
Common stock subject to possible redemption | 66,150,880 | $ 66,150,880 | $ 66,150,880 | ||
Public Warrants | |||||
Class of Warrant or Right [Line Items] | |||||
Proceeds allocated to Warrants or Rights | (322,500) | ||||
Public Rights | |||||
Class of Warrant or Right [Line Items] | |||||
Proceeds allocated to Warrants or Rights | $ (5,160,000) |
Private Placement (Details)
Private Placement (Details) - USD ($) | 7 Months Ended | 9 Months Ended | |
May 17, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | |
Subsidiary, Sale of Stock [Line Items] | |||
Proceeds from sale of public units through public offering | $ 0 | $ 64,500,000 | |
Private Placement | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of units sold | 398,892 | ||
Purchase price, per unit | $ 10 | ||
Proceeds from sale of public units through public offering | $ 3,988,920 | ||
Private Placement | Sponsor A | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of units sold | 349,032 | ||
Proceeds from sale of public units through public offering | $ 3,490,320 | ||
Private Placement | Sponsor B | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of units sold | 49,860 | ||
Proceeds from sale of public units through public offering | $ 498,600 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
Mar. 19, 2021 | Sep. 30, 2022 | Jun. 30, 2021 | Sep. 30, 2022 | Dec. 31, 2021 | May 17, 2022 | |
Related Party Transaction [Line Items] | ||||||
Class B common stock issued to initial stockholders | $ 25,000 | |||||
Promissory Note with Related Party | ||||||
Related Party Transaction [Line Items] | ||||||
Outstanding balance | $ 350,000 | |||||
Administrative Services Agreement | ||||||
Related Party Transaction [Line Items] | ||||||
Expenses per month | $ 10,000 | |||||
Service fees incurred | $ 36,129 | 46,129 | ||||
Service fees accrued | $ 46,129 | $ 0 | ||||
Related Party Loans | ||||||
Related Party Transaction [Line Items] | ||||||
Price of warrant | $ 10 | $ 10 | ||||
Working capital loan | $ 0 | $ 0 | ||||
Founder Shares | ||||||
Related Party Transaction [Line Items] | ||||||
Class B common stock issued to initial stockholders | $ 400,000 |
Related Party Transactions - Fo
Related Party Transactions - Founder Shares (Details) | 9 Months Ended | ||||||
Dec. 28, 2021 USD ($) $ / shares shares | Dec. 22, 2021 shares | May 28, 2021 shares | Apr. 07, 2021 shares | Sep. 30, 2022 D $ / shares | Jun. 03, 2022 shares | May 17, 2022 shares | |
Sponsor | |||||||
Related Party Transaction [Line Items] | |||||||
Maximum shares subject to forfeiture | 112,500 | ||||||
Founder Shares | |||||||
Related Party Transaction [Line Items] | |||||||
Shares subject to forfeiture | 225,000 | 112,500 | |||||
Stock converted basis, percentage | 1 | ||||||
Aggregate consideration | $ | $ 25,000 | ||||||
Issued price per share | $ / shares | $ 0.01 | ||||||
Percentage of certain limited exceptions, not to transfer, assign or sell any of their founder shares | 50 | ||||||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 20 days | ||||||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D | 30 | ||||||
Threshold Period After Business Combination Specified With Respect To The Remaining Of Insider Shares | 50 | ||||||
Closing shares price per share | $ / shares | $ 12.50 | ||||||
Founder Shares | Class A Common Stock | |||||||
Related Party Transaction [Line Items] | |||||||
Converted shares | 1,725,000 | ||||||
Founder Shares | Class B Common Stock | |||||||
Related Party Transaction [Line Items] | |||||||
Shares holdings stock | 1,725,000 | ||||||
Stock split | 1.5 for 1 stock split | ||||||
Founder Shares | Sponsor A | |||||||
Related Party Transaction [Line Items] | |||||||
Aggregate consideration | $ | $ 23,600 | ||||||
Founder Shares | Sponsor A | Class A Common Stock | |||||||
Related Party Transaction [Line Items] | |||||||
Aggregate number of shares owned | 1,628,400 | ||||||
Founder Shares | Sponsor A | Class B Common Stock | |||||||
Related Party Transaction [Line Items] | |||||||
Shares of acquisition | 1,357,000 | ||||||
Shares of surrender | 271,400 | ||||||
Founder Shares | Sponsor B | Class A Common Stock | |||||||
Related Party Transaction [Line Items] | |||||||
Aggregate number of shares owned | 96,600 | ||||||
Aggregate consideration | $ | $ 1,400 | ||||||
Founder Shares | Sponsor B | Class B Common Stock | |||||||
Related Party Transaction [Line Items] | |||||||
Shares of acquisition | 80,500 | ||||||
Shares of surrender | 16,100 |
Commitments and Contingencies (
Commitments and Contingencies (Details) | May 17, 2022 USD ($) item shares |
Commitments and Contingencies | |
Maximum number of demands for registration of securities | item | 3 |
Gross proceeds | $ | $ 4,500,000 |
Initial Public Offering | |
Commitments and Contingencies | |
Gross proceeds | $ | $ 1,290,000 |
Percentage of cash underwriting discount | 2 |
Percentage of deferred fee | 3.5 |
Deferred underwriting commission | $ | $ 2,257,500 |
Over-allotment option | |
Commitments and Contingencies | |
Number of maximum public units purchase | shares | 900,000 |
Number of units sold | shares | 450,000 |
Over-allotment option | Class A Common Stock | |
Commitments and Contingencies | |
Number of shares in a unit | shares | 1 |
Stockholders' Equity - Preferre
Stockholders' Equity - Preferred Stock Shares (Details) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Stockholders' Equity | ||
Preferred shares, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 |
Preferred shares, shares issued | 0 | 0 |
Preferred shares, shares outstanding | 0 | 0 |
Stockholders' Equity - Common S
Stockholders' Equity - Common Stock Shares (Details) | Dec. 28, 2021 shares | Dec. 22, 2021 shares | Sep. 30, 2022 $ / shares shares | Jun. 03, 2022 shares | May 23, 2022 shares | Dec. 31, 2021 $ / shares shares |
Class A Common Stock | ||||||
Class of Stock | ||||||
Common shares, shares authorized (in shares) | 50,000,000 | |||||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | |||||
Number of Class A common stock issued upon conversion of each share (in shares) | 1,725,000 | |||||
Ratio to be applied to the stock in the conversion | 1 | |||||
Common shares, shares issued (in shares) | 2,011,392 | |||||
Common shares, shares outstanding (in shares) | 2,011,392 | |||||
Aggregated shares issued upon converted basis (in percent) | 20% | |||||
Class A Common Stock Subject to Redemption | ||||||
Class of Stock | ||||||
Class A common stock subject to possible redemption, outstanding (in shares) | 6,450,000 | 6,450,000 | ||||
Class A Common Stock Subject to Redemption | Over-allotment option | ||||||
Class of Stock | ||||||
Maximum shares subject to forfeiture | 225,000 | |||||
Class B Common Stock | ||||||
Class of Stock | ||||||
Common shares, shares authorized (in shares) | 2,000,000 | 2,000,000 | ||||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | ||||
Common shares, shares issued (in shares) | 0 | 0 | ||||
Common shares, shares outstanding (in shares) | 0 | 0 | ||||
Sponsor | ||||||
Class of Stock | ||||||
Maximum shares subject to forfeiture | 112,500 | |||||
Sponsor | Class B Common Stock | ||||||
Class of Stock | ||||||
Number of Class A common stock issued upon conversion of each share (in shares) | 1,725,000 | 1,725,000 | ||||
Founder Shares | Class A Common Stock | ||||||
Class of Stock | ||||||
Common shares, shares issued (in shares) | 112,500 | |||||
Founder Shares | Class B Common Stock | ||||||
Class of Stock | ||||||
Stockholders' equity stock split | 1.5 for 1 stock split |
Stockholders' Equity - Rights a
Stockholders' Equity - Rights and Warrants (Details) | 9 Months Ended | |
May 17, 2022 $ / shares shares | Sep. 30, 2022 $ / shares shares | |
Class of Stock | ||
Number of shares issuable per warrant or right | shares | 1 | |
Exercise price of warrants | $ 11.50 | |
Share price | $ 16.50 | |
Percentage of gross proceeds on total equity proceeds threshold minimum | 60 | |
Number of trading day period | 20 days | |
Rights percent based on market value and newly issued price | 180 | |
Redemption price per public warrant (in dollars per share) | $ 0.01 | |
Redemption period | 30 days | |
Maximum threshold period | 30 days | |
Number of trading days | 10 days | |
Warrants | ||
Class of Stock | ||
Share price | $ 9.20 | |
Rights percent based on market value and newly issued price | 115 | |
Maximum threshold period | 20 days | |
Redemption Trigger Price | ||
Class of Stock | ||
Share price | $ 16.50 | |
Initial Public Offering | Warrants | ||
Class of Stock | ||
Warrants expiration term | 5 years | 5 years |
Redemption period | 30 days | |
Class A Common Stock | ||
Class of Stock | ||
Number of shares issuable per warrant or right | shares | 0.125 | |
Class A Common Stock | Warrants | ||
Class of Stock | ||
Share price | $ 9.20 | |
Class A Common Stock | Initial Public Offering | Warrants | ||
Class of Stock | ||
Number of shares issuable per warrant or right | shares | 1 | |
Exercise price of warrants | $ 11.50 |
FAIR VALUE MEASUREMENTS (Detail
FAIR VALUE MEASUREMENTS (Details) - Recurring | Sep. 30, 2022 USD ($) |
Assets: | |
Marketable Securities in the Trust Account | $ 66,150,880 |
Quoted Prices in Active Markets (Level 1) | |
Assets: | |
Marketable Securities in the Trust Account | $ 66,150,880 |